Ignite Creation Date:
2024-05-06 @ 7:03 PM
Last Modification Date:
2024-10-26 @ 2:59 PM
Study NCT ID:
NCT05880732
Status:
COMPLETED
Last Update Posted:
2023-05-30
First Post:
2023-04-05
Brief Title:
Magnesium Sulfate on Postoperative Pain
Sponsor:
Pamukkale University
Organization:
Pamukkale University
Study Overview
Official Title:
The Effect of Preemptive Magnesium Sulfate on Postoperative Pain in Patients Undergoing Mastectomy
Status:
COMPLETED
Status Verified Date:
2023-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Breast cancer is the most diagnosed type of cancer in women in Turkey and in the world According to the World Health Organization data the rate of newly diagnosed breast cancer was reported as 116 in 20181 Acute postoperative pain occurs in 40 of patients undergoing surgery for breast cancer2 In the early postoperative period opioids are commonly used analgesics in the treatment of pain but they have various side effects such as gastrointestinal urinary and respiratory symptoms3 Non-opioid analgesics can be used to reduce opioid use and thus limit its side effects Magnesium sulfate MgSO4 is an N-Methyl D-Aspartate NMDA receptor antagonist that has been used for postoperative analgesia and reducing both the duration and intensity of pain by preventing central sensitization in response to peripheral painful stimulus4-9 The primary aim of this study is to investigate the postoperative analgesic efficacy of MgSO4 in patients who were scheduled for mastectomy with the diagnosis of breast cancer The secondary aim of our study is to evaluate the changes in perioperative vital signs that may occur due to MgSO4
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None